The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21 years

被引:30
作者
Malik, A. N. J. [1 ]
Morris, R. W. [2 ]
Ffytche, T. J. [3 ]
机构
[1] Moorfields Eye Hosp, London EC1V 2PD, England
[2] UCL, Dept Primary Care & Populat Hlth, London, England
[3] Hosp Trop Dis, London NW1 0PE, England
关键词
leprosy; ocular complications; prevalence; risk factors; MULTIDRUG THERAPY; MULTIBACILLARY LEPROSY; 2-YEAR COURSE; EYE DISEASE; MANIFESTATIONS; MORBIDITY; DIAGNOSIS; STATES; INDIA; NEPAL;
D O I
10.1038/eye.2011.43
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective The objective of this study was to determine the prevalence of ocular complications and blindness among leprosy patients presenting in the United Kingdom. Methods Observational prospective study. Results A total of 126 consecutive leprosy patients attending their ophthalmic visit were examined, out of which 18 patients were blind in one eye (14.3%) and five patients were blind in both the eyes (4.0%). Visual acuity of >= 6/18 was present in 96 patients (76.2%). A total of 65 patients (51.6%) had an ocular complication and 28 patients (22.2%) had a sight-threatening leprosy complication (lagophthalmos, severe corneal, or iris disease). The most common ocular complications were impaired lid closure (24 patients, 19%), impaired corneal sensation (20 patients, 15.9%), cataract (20 patients, 15.9%), mild corneal opacity (17 patients, 13.5%), and iris atrophy (17 patients, 13.5%). Impaired corneal sensation was associated with vision < 6/18 (P < 0.001, OR 13.5, 95% CI 5.14-35.44) and vision < 3/60 (P = 0.01 OR 6.42, 95% CI 2.15-19.15). Impaired lid closure was significantly associated with increasing age (P = 0.029, OR 1.039, 95% CI 1.0-1.08) and vision < 3/60 (P = 0.03, OR 6.06, 95% CI 1.81-20.24). Conclusion There is a significant rate of ocular complications and blindness seen in leprosy patients in the United Kingdom, and over one in five had a potentially sight-threatening ocular complication. Health professionals and all leprosy patients, including those cured of the disease, need to be aware that new eye symptoms and signs require prompt ophthalmology review to prevent avoidable blindness, due to the life-long risk of sight-threatening ocular complications. Eye (2011) 25, 740-745; doi:10.1038/eye.2011.43; published online 18 March 2011
引用
收藏
页码:740 / 745
页数:6
相关论文
共 29 条
[1]  
[Anonymous], REP GLOB FOR EL LEPR
[2]  
BULL OB, 1873, LEPROUS DIS EYE
[3]  
Courtright P, 2002, LEPROSY REV, V73, P225
[4]  
COURTRIGHT PD, 1988, INT J LEPROSY, V56, P566
[5]   OCULAR MANIFESTATIONS OF LEPROSY IN A NONINSTITUTIONALIZED COMMUNITY IN THE UNITED-STATES [J].
DANA, MR ;
HOCHMAN, MA ;
VIANA, MAG ;
HILL, CH ;
SUGAR, J .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (05) :626-629
[6]   Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy [J].
Daniel, E. ;
Ffytche, T. J. ;
Kempen, J. H. ;
Rao, P. S. S. Sundar ;
Diener-West, M. ;
Courtright, P. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (08) :949-954
[7]   Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy [J].
Daniel, E ;
ffytche, TJ ;
Rao, PSSS ;
Kempen, JH ;
Diener-West, M ;
Courtright, P .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2006, 90 (05) :568-573
[8]   Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort [J].
Daniel, E ;
Koshy, S ;
Rao, GS ;
Rao, PSSS .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (12) :1336-1340
[9]   PREVALENCE OF OCULAR MANIFESTATIONS OF LEPROSY IN PORT-MORESBY, PAPUA-NEW-GUINEA [J].
DETHLEFS, R .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1981, 65 (04) :223-225
[10]  
Ffytche T J, 1998, Indian J Lepr, V70, P49